Schechter Investment Advisors, LLC Eli Lilly & CO Transaction History

Schechter Investment Advisors, LLC

$997 Million
Q3 2024

A detailed history of Schechter Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 7,093 shares of LLY stock, worth $5.63 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

7,093

Previous 7,080 0.18%

Holding current value

$5.63 Million

Previous $6.41 Million 1.98%

% of portfolio

0.63%

Previous 0.66%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $10,037 - $12,480	13 Added 0.18%	7,093 $6.28 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $10,148 - $12,726	14 Added 0.2%	7,080 $6.41 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $37,900 - $50,705	64 Added 0.91%	7,066 $5.5 Million
Q4 2023 Jan 17, 2024	BUY	$525.19 - $619.13 $2,625 - $3,095	5 Added 0.07%	7,002 $4.08 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $249,517 - $343,998	574 Added 8.94%	6,997 $3.76 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $139,594 - $186,654	398 Added 6.61%	6,423 $3.01 Million
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $207,190 - $243,334	667 Added 12.45%	6,025 $2.07 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $587,150 - $684,147	-1,826 Reduced 25.42%	5,358 $1.96 Million
Q3 2022 Nov 04, 2022	BUY	$296.48 - $337.87 $681,607 - $776,763	2,299 Added 47.06%	7,184 $2.32 Million
Q2 2022 Nov 03, 2022	BUY	$278.73 - $327.27 $1.36 Million - $1.6 Million	4,885 New	4,885 $1.58 Million
Q1 2022 Nov 18, 2022	SELL	$234.69 - $291.66 $661,825 - $822,481	-2,820 Reduced 39.25%	4,364 $1.25 Million
Q4 2021 Dec 27, 2022	SELL	$224.85 - $279.04 $824,300 - $1.02 Million	-3,666 Reduced 51.03%	3,518 $971,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.

Account

Schechter Investment Advisors, LLC Eli Lilly & CO Transaction History